Gilead Sciences Inc , maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
), maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
By the end of next month, Gilead said it expects to have manufactured enough of the drug to treat more than 140,000 patients, and it plans to donate that supply to hospitals. He said the FDA could issue an emergency use authorization for remdesivir, but Gilead is also seeking standard regulatory approval of the drug.
While the data will need more analysis to know just how well the drug might work and for which patients with COVID-19, it was hailed by U.S. health officials as highly significant since it clearly had an effect on the disease for which there are currently no approved treatments or vaccines. More detailed results of the U.S. study are expected next month. There are several other studies also looking at remdesivir for the coronavirus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
Read more »
Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatmentGilead says preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of remdesivir improved, and more than half were discharged from the hospital within 2 weeks.
Read more »
Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Gilead Sciences said its phase 3 study for the antiviral remdesivir demonstrated that patients with severe Covid-19 taking the drug over a five-day treatment had similar improvement compared with those taking the 10-day course.
Read more »
Stocks Rally, Dow Up 400 Points After Gilead Treatment Shows ‘Positive Data’The market got a boost from news of a potential treatment for coronavirus.
Read more »
What to watch today: Dow set to jump on positive data on possible Gilead coronavirus treatmentDow futures soar on positive data about a possible Gilead Sciences coronavirus treatment.
Read more »
Coronavirus treatment: Gilead says positive data on remdesivir coming - Business InsiderOne of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID-19 patients, Gilead said Wednesday.
Read more »